fluorodeoxyglucose f18 has been researched along with Cancer of Pharynx in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.56) | 18.2507 |
2000's | 13 (33.33) | 29.6817 |
2010's | 23 (58.97) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Dhomps, A; Dumollard, JM; Froudarakis, M; Gavid, M; Karpathiou, G; Lelonge, Y; Peoc'h, M; Prades, JM; Prevot-Bitot, N; Vieville, M | 1 |
Groshek, L; He, J; Teinor, J | 1 |
Choi, YJ; Jang, JY; Ki, YK; Kim, H; Kim, IJ; Kim, SJ; Kim, WT; Pak, KJ; Seol, YM; Wang, SG; Yi, KI | 1 |
Chen, TP; Chiu, NT; Lin, YH; Liu, CS; Yi, WL | 1 |
Chang, KC; Chen, SW; Hsieh, TC; Kao, CH; Wang, YC; Yen, KY | 1 |
Beadle, BM; Debnam, JM; Frank, SJ; Fuller, CD; Garden, AS; Glisson, BS; Gunn, GB; Morrison, WH; Phan, J; Rosenthal, DI; Sturgis, EM | 1 |
Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
Chen, SW; Hsieh, TC; Kao, CH; Liang, JA; Yen, KY | 1 |
Fujimoto, Y; Hasegawa, Y; Hiramatsu, M; Itoh, Y; Kato, K; Naganawa, S; Nakashima, T; Suzuki, H | 1 |
Hata, M; Inoue, T; Katahira-Suzuki, R; Omura-Minamisawa, M; Taguchi, T; Takano, S; Tateishi, U | 1 |
Cho, YS; Choe, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH | 1 |
Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
Chen, RY; Chen, SW; Chen, YH; Chow, NH; Hsieh, TC; Kao, CH; Liang, JA; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 2 |
Hosono, M; Ishikawa, K; Kanamori, S; Matsuura, T; Nakamatsu, K; Nishimura, Y; Shibata, T; Tachibana, I | 1 |
Chen, RY; Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Shen, WC; Yen, KY | 1 |
Ejima, Y; Ishihara, T; Kitajima, K; Kiyota, N; Komatsu, H; Nibu, KI; Otsuki, N; Sasaki, R; Suenaga, Y; Takahashi, S | 1 |
Furukawa, M; Kondo, S; Minato, H; Murono, S; Wakisaka, N; Yoshizaki, T | 1 |
Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Ogawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
Ahn, MJ; Ahn, YC; Baek, CH; Choi, JY; Chung, MK; Hyun, SH; Jang, JY; Jeong, HS; Kim, HJ; Ko, YH; Park, K; Park, SG; Son, YI | 1 |
Ang, KK; Cannon, BA; Chao, KS; Chronowski, GM; Frank, SJ; Garden, AS; Ginsberg, LE; Lee, JJ; Lippman, SM; Macapinlac, HA; Moeller, BJ; Morrison, WH; Rana, V; Rosenthal, DI; Schwartz, DL; Sturgis, EM; Weber, RS; Williams, MD | 1 |
Boerman, OC; Bussink, J; Kaanders, JH; Oyen, WJ; Schinagl, DA; Troost, EG | 1 |
Hanaoka, K; Hosono, M; Kanamori, S; Nakamatsu, K; Nishimura, Y; Okubo, M; Okumura, M; Shibata, T | 1 |
Grillone, G; Meibom, S; Subramaniam, RM; Surasi, DS | 1 |
Abdoli, M; El Naqa, IM; Fuentes, CL; Zaidi, H | 1 |
Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Geiger, B; Heusner, TA; Lehnerdt, G; Mattheis, S; Treffert, J | 1 |
Chen, SW; Kao, CH; Liang, JA; Liao, CY; Lin, SC; Wang, YC; Yang, SN; Yen, KY | 1 |
Chen, HH; Chen, IH; Fan, KH; Huang, SF; Kang, CJ; Liao, CT; Lin, CY; Wang, HM; Yen, TC | 1 |
Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
Daisne, JF; Geets, X; Gregoire, V; Hamoir, M; Lonneux, M | 1 |
Daisne, JF; Duprez, T; Grégoire, V; Hamoir, M; Lonneux, M; Reychler, H; Weynand, B | 1 |
Alavi, A; Bural, GG; Kumar, R; Mavi, A | 1 |
Bares, R; Claussen, C; Claussen, CD; Dammann, F; Eschmann, S; Hoffman, J; Horger, M; Mueller-Berg, M; Schlemmer, H | 1 |
Daisne, JF; Duprez, T; Geets, X; Grégoire, V; Lonneux, M; Tomsej, M | 1 |
Coche, E; Cosnard, G; Duprez, T; Geets, X; Grégoire, V; Lee, JA; Lonneux, M; Tomsej, M | 1 |
Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
Bongers, V; Hordijk, GJ; Terhaard, CH; van Rijk, PP | 1 |
Emri, M; Erdélyi, L; Erfán, J; Esik, O; Füle, E; Lengyel, E; Lengyel, Z; Olajos, J; Trón, L | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Cancer of Pharynx
Article | Year |
---|---|
Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2017 |
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
Topics: Body Burden; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiation Protection; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Relative Biological Effectiveness; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
37 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Pharynx
Article | Year |
---|---|
Correlation Between Semiquantitative Metabolic Parameters After PET/CT and Histologic Prognostic Factors in Laryngeal and Pharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Rare case of metastatic small cell carcinoma of the nasopharynx to the pancreas.
Topics: Carcinoma, Small Cell; Chemoradiotherapy; Cholecystectomy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasopharynx; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Splenectomy | 2020 |
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome; Young Adult | 2017 |
Parapharyngeal Ganglioneuroma Detected by 18F-FDG PET/CT in a Patient With Hodgkin Lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Ganglioneuroma; Hodgkin Disease; Humans; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Concurrent chemo-radiotherapy potentiates vascular inflammation: increased FDG uptake in head and neck cancer patients.
Topics: Antineoplastic Agents; Arteritis; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Incidence; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Smoking; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2014 |
Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Clinical Significance of Incidental 18F-FDG Uptake in the Pyriform Sinus Detected by PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Pyriform Sinus; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2016 |
Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2017 |
Correlation of pretreatment
Topics: Adult; Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Vascular Endothelial Growth Factor A | 2017 |
[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2017 |
A solitary fibrous tumor arising in the parapharyngeal space, with MRI and FDG-PET findings.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Fibrous Tumors | 2009 |
Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2009 |
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Correlation of segmented metabolic tumor volume with outcome--letter.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution | 2010 |
Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2010 |
F-18 FDG PET/CT imaging of a parapharyngeal hemangioma.
Topics: Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2012 |
Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study.
Topics: Aged; Aged, 80 and over; Endoscopy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Respiratory System; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; User-Computer Interface | 2012 |
Pretreatment maximal standardized uptake value of the primary tumor predicts outcome to radiotherapy in patients with pharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Serpins | 2013 |
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Topics: Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Methionine; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Laryngeal Neoplasms; Laryngectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG uptake in intercostal muscles is an indicator of severe respiratory disease.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intercostal Muscles; Male; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiation Pneumonitis; Radiopharmaceuticals; Severity of Illness Index | 2004 |
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, Spiral Computed | 2007 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[PET scan in patients with epipharyngeal tumors].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |